CRB Inverbío

CRB Inverbío operates as a specialized Private Venture Capital Management firm with a strategic focus on Health Technologies. Established by an experienced multi-disciplinary executive team, the company has built a reputation for identifying and nurturing promising healthcare innovations. Their investment approach combines deep sector knowledge with hands-on operational expertise, allowing them to provide value beyond capital to their portfolio companies. With headquarters in both Madrid and Barcelona, CRB maintains strong connections to Europe's most dynamic innovation ecosystems.

The firm's investment history demonstrates a methodical expansion across the healthcare technology spectrum. CRB has successfully managed three distinct funds, each targeting specific segments: Fund I concentrated on biotechnology ventures, Fund II emphasized medical technology companies, and their subsequent fund focused exclusively on digital health innovations. This strategic specialization has allowed CRB to develop deep domain expertise and build a diverse portfolio of healthcare technology companies at various stages of development, from early-stage startups to growth-phase enterprises.

Currently, CRB is advancing its investment strategy with the incorporation of Fund III (CRB Digital Health III), which represents a continued commitment to the rapidly evolving digital health sector. This specialized fund leverages the team's extensive experience across the healthcare innovation spectrum, including startups, scaleups, corporate environments, and public health institutions. The fund's focus areas include telemedicine platforms, AI-driven diagnostic tools, remote patient monitoring systems, and other transformative digital health solutions that address critical healthcare challenges and inefficiencies.

What distinguishes CRB in the competitive venture capital landscape is their hybrid approach combining financial acumen with healthcare expertise. Their investment team features professionals with backgrounds spanning medicine, biotechnology, healthcare administration, and technology development. This multidisciplinary perspective enables them to evaluate potential investments with exceptional thoroughness and provide meaningful strategic guidance to portfolio companies. CRB typically invests in early and growth-stage companies with proven concepts and clear paths to market, focusing on innovations that demonstrate potential for significant healthcare impact and sustainable business models. Their geographic positioning in Spain provides a unique vantage point to access both Southern European innovation and broader European healthcare markets.